Skip to content

Georgia · Nonprofit

Cure VCP Disease Inc

Cure VCP Disease Inc (Georgia) receives grants from 18 organizations whose IRS filings report $1,008,215 to it, the largest being Silicon Valley Community Foundation ($624,000). 7 of them have funded it in more than one year, and 91% of the money arrives through donor-advised or pass-through sponsors rather than from an institution directly.

Revenue FY2025
$424k
Funders on record
18
Grants received
$1.0M
Net assets
$472k
7/18 repeat fundersgrants exceed reported revenue in one year
01What it does

What Cure VCP Disease Inc does

Mission

Research (Tools, Collaborations, Models and Convenings)

As stated on its FY2025 Form 990.

Programs

  1. We awarded two research grants 1.) to Genethon to investigate gene editing approaches in VCP iPSCs and 2.) through Uplifting Athletes for a young investigator

    $56,762 spentof which $56,762 as grants
    19% of program spending
  2. Coordinating the VCP Research Network, hostinga patient registry, creating scientific models to share with scientists, and hosting the scientific focus group

    $196,402 spent
    66% of program spending
  3. Supporting patients through genetic testing stipends, hosting support groups and educational webinars

    $42,703 spent
    14% of program spending
  4. Expenses for the 2026 VCP Conference -expecting 100 researchers and patients to attend

    $923 spent
    0% of program spending

The 4 programs described on its FY2025 Form 990, listed largest first by expense. Program spending in total: $296,790.

02The organization over time

The organization over time

Each line starts at 100 in 2020, so what you read is the shape rather than the size: 150 means half as much again as 2020, 50 means half. The number beside each label in the key is where it ended. The shaded band is where the middle 50% of its peers' revenue would sit, given their growth.

100 = 20202020 Revenue 100 ($107k) Expenses 100 ($27k) Net assets 100 ($175k)2021 Revenue 289 ($309k) Expenses 523 ($142k) Net assets 195 ($341k)2022 Revenue 305 ($326k) Expenses 960 ($261k) Net assets 233 ($407k)2023 Revenue 394 ($421k) Expenses 1290 ($350k) Net assets 273 ($478k)2024 Revenue 298 ($319k) Expenses 1362 ($370k) Net assets 244 ($427k)2025 Revenue 397 ($424k) Expenses 1393 ($378k) Net assets 270 ($472k)
202020212022202320242025
Revenue (397)Expenses (1393)Net assets (270)Peer revenue range

Balance sheet

Total assets and total liabilities at each year end, in dollars. The largest one-year move in total assets was 2020 to 2021, from $175k to $341k (+95%).

$175k
$341k
$407k
$489k
$432k
$485k
202020212022202320242025
Total assetsTotal liabilities

How it's funded, over time

Each bar is one year's revenue split into where it came from, and every bar is the same height — these are shares, not amounts, so a year that raised twice as much looks the same size. Hover a bar for the split.

2020
2021
2022
2023
2024
2025
ContributionsProgram revenueInvestmentOther

97% of Cure VCP Disease Inc’s revenue is contributions — more donation-reliant than the typical peer (82% for the typical peer).

This organization
Typical peer · 14,893 orgs

Surplus & reserves

Operating surplus or deficit each year, and months of liquidity in hand. 1 of the last 6 reported years ran a deficit.

$80k
’20
$166k
’21
$65k
’22
$71k
’23
−$51k
’24
$45k
’25
15
months of
reserve

Leadership and staff

The officers, directors, trustees and key employees listed on each return. Joined and no longer listed compare each filing with the year before, matching people by surname and first initial; a year after a gap, or a roster under three people, has no comparison.

Chief executive

Nathan Peck

CEO

As listed on its FY2025 Form 990.

20212022202320242025
Listed87969
Joined·+0+2+0+3
No longer listed·1030
03Who funds it

Who funds it, year by year

2018 → 2023: the base broadened from 1 funder to 7 funders, grant income rose $5k → $18k.

7 of 18 of your funders are donor-advised or pass-through sponsors (tagged DAF) — 91% of grant dollars received. That money is really individual donors directing a sponsor; the institutions to cultivate are the non-DAF funders.

From the IRS filings of Cure VCP Disease Inc’s funders (the co-funder graph). Association, not causation. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.

How concentrated its funding is

Cure VCP Disease Inc leans on a few funders — its largest provides 62% of grant income and the top three 80%; half comes from just 1 funder.

the vertical line marks half of all grant income — 1 funder to its left

95% of the income these shares are computed over arrives through pass-through sponsors or from payers whose filings do not say what kind of payment it is. Concentration is still measured over all of it, because the money is real; what it does not support is a claim about how many institutions have chosen to fund Cure VCP Disease Inc.

62%
largest funder
80%
top three
~2
effective funders

Largest funder’s share by year: 2018 100% · 2019 66% · 2020 96% · 2021 90% · 2022 65% · 2023 43% — diversifying over time.

“Effective funders” = inverse Herfindahl index (1 / Σ shareᵢ²) — the number of equal-sized funders that would give the same concentration. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.

How long its funders stay

75% of Cure VCP Disease Inc's funders are still giving 3 years after their first grant; 39% give in more than one year at all.

first grant+1y+2y+3y

Share of funders still giving k years after their first recorded grant, pooled across every acquisition cohort. A funder counts as retained in a year only if it made a grant that year. Measured to FY2023, the last fiscal year that has finished arriving — a funder cannot be counted as lapsed in a year most filers have not reached.

Where its funders are

91% of Cure VCP Disease Inc's grant income arrives through donor-advised or pass-through sponsors, whose addresses record where the money is held rather than where the donor is. Of the $88k that is directly attributable, 99% of it comes from funders outside Georgia, across 8 states.

IL
NY
MA
OH
KY
DC
GA
FL

In-state vs out-of-state, by year

’19
’20
’21
’22
’23
Georgia out of state home

Funder states come from each funder’s own filing. $921k arriving through sponsors registered in 7 states is excluded from the map and the split above: a sponsor holds money on a donor’s behalf, so its registered address would place those dollars somewhere no donor need ever have been. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.

04Its place in the field

Against its field

Cure VCP Disease Inc has grown faster than three-quarters of the 7,883 health nonprofits its size.

Operating margin11% · above the median
Months of reserve14.8mo · above the median
Revenue growth (annualized)32% · top quartile

this organization peer median middle 50% of peers· 7,883 health nonprofits $100k–$1M, FY2025

Organizations like Cure VCP Disease Inc

Organizations whose mission and program text most resemble this one, by semantic similarity over every organization in the US filings — the closest peers, and often the clearest route to shared or prospective funders.

In Georgia

Nationally

05Profile & governance

Read directly from this organization’s own Form 990, as neutral context.

Where the money goes

78% of spending goes to programs.

Program 78%Management 15%Fundraising 6%

Governance

8
board members
100%
independent
✓Conflict-of-interest policy–Whistleblower policy–Document retention✓Board reviewed the 990–Audited financials

Public support

78%

Share of support from the public (Schedule A) — the basis for its public-charity status.

Footprint & structure

Files a return copy in 18 states

WA
MN
IL
MI
OR
OH
PA
NJ
CT
CA
CO
MO
TN
NC
DC
GA
TX
FL

Screen this organization

A dated, signed PDF of the compliance screen for Cure VCP Disease Inc: IRS status (Business Master File, Publication 78, auto-revocation), the OFAC sanctions lists, the Internal Revenue Bulletin, and California registration, with the Rev. Proc. 2018-32 §8.01 reliance elements stated element by element. Generated from the current files at the moment you download it.

A paid feature, included from the $75 plan up. Sign in to download.

Screens are triage, not determinations; a source that cannot be read reports not screened, never clear. Screen this nonprofit · How the screen works · on the API as GET /api/screening/{ein}?format=pdf

Questions and answers

Who funds Cure VCP Disease Inc?
Cure VCP Disease Inc (Georgia) receives grants from 18 organizations whose IRS filings report $1,008,215 to it, the largest being Silicon Valley Community Foundation ($624,000). 7 of them have funded it in more than one year, and 91% of the money arrives through donor-advised or pass-through sponsors rather than from an institution directly.
How many funders does Cure VCP Disease Inc have?
IRS filings report 18 organizations giving $1,008,215 in grants to Cure VCP Disease Inc, 7 of which have funded it in more than one year.
Who is the largest funder of Cure VCP Disease Inc?
Silicon Valley Community Foundation is the largest funder on record, with $624,000 in grants. The full list of funders is on this page.
How can an organization like Cure VCP Disease Inc find more funders?
Start with the funders already giving here, then look at the foundations that back similar organizations in Georgia. The funding by cause and by state pages list the largest funders for a given area and how to approach them.

These figures are read directly from IRS Form 990 / 990-PF e-file XML: this organization’s own return for FY2025 (financials across 2020–2025), and the filings of 18 funders that report grants to it. “On record” means captured in the filings we have parsed — a funder that does not e-file, or whose grant detail is not itemized, will not appear. Filings run roughly 12–24 months behind. Trends on this page end at FY2023, the last fiscal year that has finished arriving; later years are shown and marked, and move no figure. Data on this page was exported October 14, 2026. What this page cannot tell you · view filing